S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction Adenocarcinoma

Clinical trial NCT04989985 · RECRUITING

Trial details

NCT number: NCT04989985
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Gastroesophageal Junction Adenocarcinoma Chemotherapy Effect

Start date: 2021-09-01
Primary completion: 2024-08-01
Enrollment: 302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.